chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My husband & I both received our Covid-19 vaccines between 26March - 01May2021. We both tested positive for Covid-19 last week; My husband & I both received our Covid-19 vaccines between 26March - 01May2021. We both tested positive for Covid-19 last week; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 01May2021 as single dose and first dose of (BNT162B2, solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced my husband & i both received our covid-19 vaccines between 26march - 01may2021. we both tested positive for covid-19 last week. On an unspecified date the patient underwent lab tests and procedures which included sars-cov-2 test positive results. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101193487 Same reporter/drug/AE, different patient
Headache, Arthralgia, Chills, nasal congestion Narrative:  Other Relevant History:
inserted vaccine with a vanish point syringe.  pushed the plunger to inject vaccine vanish point make a load popping sound all vaccine came out the backend at the plunger on  to vaccinators hand patent  was revaccinated without failure of syringe system
24 hours after receiving vaccine had fever of 100, swelling and redness of injection site, flu like symptoms, body aches.  Symptoms improved/resolved after 36 hours. 2 weeks later injection site became red, swollen, hot to touch, painful, achy and tiredness.
Pt recvd 3rd dose of Hep B vax in JAN92  & lab eval revealed a neg Hep B surface antibody; pt recvd booster dose on 13APR92 & w/in an hr of vax pt devel macular, papular rash & itching;
Erythema, warmth and pain distal to site of injection by a few cm  also presyncope and transient hypotension.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 79-year-old female patient who received SHINGRIX (batch number FZ3ND, expiry date 2nd February 2021) for prophylaxis. On 21st September 2018 16:38, the patient received the 1st dose of SHINGRIX 5 ml. On 21st September 2018, less than a day after receiving SHINGRIX the patient experienced injection site pain, injection site erythema, injection site warmth and injection site itching. The patient was treated with hydrocortisone. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site warmth and injection site itching were recovering/resolving. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site warmth and injection site itching to be related to SHINGRIX. Additional details were reported as follows: The patient reported pain and soreness at the injection site the evening of the injection. The patient also described it as tender. Over time the injection site area became red, itchy and warm. The affected area was described to be the size of a nickel. The second red, itchy and warm area presented located an inch below the injection site area. This patch measured either 4 by 4 inches or 5 by 3 inches. The exact measurement was unclear. The time frame of presentation was also unclear. It was started on 21st September 18 and continued through 4th October 2018 when the patient visited the pharmacist who treated the areas with hydrocortisone cream. The patient then sought medical attention at her physician's office and was offered medication which she refused. The patient called the pharmacist on Saturday (6th October 2018) and told her that the redness and itching had decreased following the hydrocortisone cream treatment.
Pulsating sounds in the ear, ringing, swooshing, discomfort, dizziness
Information has been received from a RN and a physician concerning a 10 yr old female pt with reactive airways disease and environmental allergies who on 22Apr96 was vaccinated SC with varicella virus vaccine live (lot 610251/0747B). Concomitant therapy included montelukast sodium, budesonide and allergy injections. On 02Dec05 the pt had several lesions on her abdomen and itching. On 05Dec05, she was seen by the physician and had around 20-30 lesions mainly on her trunk, in her mouth and on her scalp with itching. No treatment was ordered. There was no further information available regarding the adverse event. The pt is recovered. There was no product quality complaint reported. No additional information is expected.
Had a shot in my left arm and developed soreness of arm- not too concerning but also left armpit pain that was very annoying today
Patient received MMR vaccine on June 13 2022 . Mother Called and left a voicemail on June 23 2022, stating that daughter had developed a fever of 102 F in the morning of June 22, 2022 and that later in the evening around 7:00 pm daughter developed a seizure. This Nurse called and left voicemail to call back to discuss adverse event, and instructed mom to give medication to keep fever down.   On June 30th mom left a voicemail stating, Patient had another seizure on Thursday, June 23, 2022 as well.  Mother stated that she had went to PCP Friday June 24th and was instructed to give Tylenol and Motrin to keep fever down and prevent any more fibril seizures from occurring. per mother child is doing well and back to normal.
Cramp in leg,have cramps in my back; pain in her hip and joints her leg, thigh pain; tightness thigh; pain in her hip and joints her leg; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramp in leg,have cramps in my back), PAIN IN EXTREMITY (pain in her hip and joints her leg, thigh pain), MUSCULOSKELETAL STIFFNESS (tightness thigh) and ARTHRALGIA (pain in her hip and joints her leg) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M80A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced MUSCLE SPASMS (Cramp in leg,have cramps in my back), PAIN IN EXTREMITY (pain in her hip and joints her leg, thigh pain), MUSCULOSKELETAL STIFFNESS (tightness thigh) and ARTHRALGIA (pain in her hip and joints her leg). At the time of the report, MUSCLE SPASMS (Cramp in leg,have cramps in my back), PAIN IN EXTREMITY (pain in her hip and joints her leg, thigh pain), MUSCULOSKELETAL STIFFNESS (tightness thigh) and ARTHRALGIA (pain in her hip and joints her leg) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided.  Treatment information not provided by the reporter.
has a headache; eyes are blurry; has been back and forth to the bathroom; This is a spontaneous report from a Pfizer sponsored program COVAX US support. A contactable female consumer (patient) of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 2 via an unspecified route of administration on 06Apr2021 (Lot number and Expiry date was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced headache, eyes are blurry and had been back and forth to the bathroom. Patient was very upset after vaccination as she thought it was the best one to take. Outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Watery diarrhea; Gas; Bloating; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 09Apr2021 08:30 (Lot number: EW0151) at the age of 73 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Lot number: EP7534, Anatomical location: Arm right), administration date: 19Mar2021, when the patient was 73 years old, for Covid-19 Immunization, reaction(s): "Sore arm". The following information was reported: DIARRHOEA (non-serious) with onset Apr2021, outcome "recovering", described as "Watery diarrhea"; FLATULENCE (non-serious) with onset Apr2021, outcome "recovering", described as "Gas"; ABDOMINAL DISTENSION (non-serious) with onset Apr2021, outcome "recovering", described as "Bloating".  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a Nurse refers to a patient of unknown demography. The nurse reported that on 08-APR-2014, the patient was administered with expired dose of ZOSTAVAX Lot # 0068AE (Expiration: 03-APR-2013) (dose and frequency were not reported). No adverse effect reported. No further information provided. Additional information has been requested.
Upper deltoid area became edematous and pruritic. Second day, whole deltoid region erythematous. Benadryl cream applied. Third day, edema increased to lower and lateral aspect of upper and lower arm with dark erythema.
major inflammation that increased from site of inoculation up to shoulder and almost to elbow; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (major inflammation that increased from site of inoculation up to shoulder and almost to elbow) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (major inflammation that increased from site of inoculation up to shoulder and almost to elbow). At the time of the report, SWELLING (major inflammation that increased from site of inoculation up to shoulder and almost to elbow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.   Reporter did not allow further contact
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (as a child). Previously administered products included ZOSTAVAX. On 26th September 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 26th September 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On 27th September 2018, the patient experienced muscle pain, fatigue, headache, shivering, injection site erythema and injection site swelling. On 29th September 2018, the patient experienced injection site rash. On 2nd October 2018, the patient experienced injection site itching. On an unknown date, the patient experienced injection site lump. On an unknown date, the outcome of the injection site pain and injection site swelling were recovering/resolving and the outcome of the muscle pain, fatigue, headache and shivering were recovered/resolved and the outcome of the injection site itching, injection site erythema and injection site lump were not recovered/not resolved and the outcome of the injection site rash was unknown. It was unknown if the reporter considered the injection site pain, muscle pain, fatigue, headache, shivering, injection site itching, injection site erythema, injection site swelling, injection site rash and injection site lump to be related to SHINGRIX. Additional details were provided as follows: At 13:00, the patient received SHINGRIX on the left arm. On the same day the patient experienced sore arm. One day after receiving SHINGRIX, the patient experienced redness and swelling (like large hive) a little below the injection site. The patient also had headache, muscle aches, shivering and fatigue. On 28th September 2018, the redness and swelling at the injection site was more. On 29th September 2018 (3 days after vaccination), the swelling started gone down, but it was still red and the redness looked like rash instead of just bright red. On the day of reporting (6 days after vaccination), she developed itching at the site. The soreness was improved but it hurts if the patient touched it. The swelling went down but there was still a lump (less than a week after vaccination) and the redness was about 2 by 4 inches.
I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 4/14/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 4/14/2023 PRESSURE ULCER OF SACRUM, UNSTAGEABLE (ULCER COVERED BY SLOUGH AND/OR ESCHAR)
This case was reported by a nurse via call center representative and described the occurrence of hives in a 25-year-old female patient who received FLULAVAL (batch number AFLLA285AA, expiry date unknown). On 4th October 2009, the patient received FLULAVAL. On 4th October 2009, immediately after receiving FLULAVAL, the patient experienced hives. On an unknown date, the patient experienced sickness. On an unknown date, the outcome of the hives and sickness were recovered/resolved. It was unknown if the reporter considered the hives and sickness to be related to FLULAVAL. Additional information was provided: The patient was sick a lot in the winter following vaccination. Since then, she had not received any additional doses of flu vaccine.
onset of extreme irritability 1/2 hr p/vax pattern of 10 mins screaming followed by 5" quiet lasted 6 hrs;
got COVID-She did take all 3 Pfizer vaccines; got COVID-She did take all 3 Pfizer vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  A 77-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got COVID-She did take all 3 Pfizer vaccines". She got COVID about 1.5 years ago (Sep or Oct in 2021) and still can't taste or smell about 90% of the time. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
blood clots; This is a spontaneous report from Pfizer sponsored program COVAX US Support. A non-contactable consumer reported that a female patient of an unspecified age (consumer's friend) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient went in and got the vaccine on behalf of her husband, because he had health issues, she developed blood clots, Consumer didn't know if she still had them, but they happened right away with her. Outcome of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received COVID-19 vaccines 12/17/20 and 1/7/2021.  On 4/21 developed nasal congestion and sore throat.  Tested positive for COVID.
Typical headaches; muscle aches; nausea; distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine.; distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine.; This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), intramuscular in the right arm on 22Jan2021 12:15 at single dose for COVID-19 immunisation. Medical history included elevated blood pressure and allergy to raw walnuts and pecans. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included biotin (BIOTIN), vitamin d nos (VITAMIN D NOS), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), fexofenadine, hydrochlorothiazide, lisinopril (LISINOPRIL/HCTZ), cetirizine. The patient previously took morphine and experienced drug hypersensitivity. On 23Jan2021 15:00, the patient experienced typical headaches, muscle aches, nausea, distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine. No treatment was received for the adverse events. Clinical outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Patient was sleeping and started shaking at around 3am uncontrollably upper and lower extremities. Was not responsive to parents and eyes rolling back. No fevers. Per parents was not conscious, however no perioral cyanosis. They called 911 and after nearly 1 minute the shaking resolved. Paramedics examined child and deemed stable with no further recommendations. No further shaking episodes or fevers since then.
generalized rash, fever & toxic appearance are reported in a pt 6 days p/vax; pt ex generalized rash & a fever of 101; pt was evaluated in ER:
Stomach pain; fever; vomiting; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 07May2021 16:45 (Batch/Lot number: unknown) at the age of 52 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Immune Compromised" (unspecified if ongoing); "Phempagus Vulgaris" (unspecified if ongoing). Concomitant medication(s) included: MYCOPHENOLATE; LEXAPRO. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not sure batch, Location of injection: Arm Right, Vaccine Administration Time: 04:45 PM), administration date: 16Apr2021, when the patient was 51 years old, for COVID-19 immunization.  The following information was reported: ABDOMINAL PAIN UPPER (non-serious) with onset 2021, outcome "recovering", described as "Stomach pain"; PYREXIA (non-serious) with onset 2021, outcome "recovering", described as "fever"; VOMITING (non-serious) with onset 2021, outcome "recovering", described as "vomiting". Therapeutic measures were not taken as a result of abdominal pain upper, pyrexia, vomiting.  Additional Information: The patient had no known allergies. Prior to vaccination, patient has not been diagnosed with COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has been tested for COVID-19 was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-202101857211 same patient/event, different dose of vaccine.
Feel lousy today; This case was reported by a consumer and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 4th November 2021, the patient received the 1st dose of Shingles vaccine. On 5th November 2021, 1 days after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was not recovered/not resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had received first Shingle shot one day before reporting and felt lousy on the day of reporting. The patient stated that she/he was told that would for day or two.
Right arm pain, mainly upper arm sore every day since vaccination, but no swelling, bruising, and has difficulty raising arm. At times throbbing pain for 3 weeks. Started day after. Unable to sleep on right side. Complained of being worse in AM. Saw Chiropractor 1/25 and will see again on 1/27 for ultrasound. Iced initially - now using heat and massage.
Pt was seen on 3/23/22, she received vaccines given (IPV#4, Tdap#1, Varicella #2) on Rt arm. Pt c/o reddness, warm to touch, hard lump on back of rt arm. rt arm feels numb and fingers are tingly. Pt has not taking any medication for pain. Pt also feeling pain in rt breast area. 2:27PM  reaction at site of HPV vaccine May be cellulitis ATB prescribed, advised to take 800mg ibuprofen Q8H with food until numbness and tingling ceases   Risks and/or benefits and potential side effects of prescribed medication were reviewed with the parent/patient and all questions answered.  Parent/patient verbalizes understanding, denies any barriers to adherence and agrees to call the clinic with any concerns. RTC in 5 days for f/u    Report reaction if no improvement with antibiotics
Initial report received from a health care professional on 25 October 2010. A 74-year-old male patient with medical history of Alzheimer's disease had received a dose of FLUZONE SV 2010-2011 (lot number U3730AA) on 06 October 2010. That evening the patient spiked a low grade fever. Over the next 2 days the patient had bowel and bladder incontinence, more difficulty with gait, and increased confusion. Two days later (08 October 2010) the primary care physician advised the wife take the patient to the emergency department. Upon admission the patient had a MRI, head CT, and lab work that were within normal limits. Hospital staff determined the subject had a reaction to the flu shot which caused all symptoms. On "01 October 2010" (date is prior to onset date of event) the patient was discharged after all symptoms had returned to baseline. Documents held by sender: None.
Fever, sweats, nausea, vomiting & shortness of breath within a few hours after injection & seen the next AM 20 hours post injection with no fever, GSVB, some nausea & vomiting no treatment.
Narrative: Covid +, moderna #2 chest pain, cough, SOB, fatigue body ache, cough x 8 days, pneumonia, fever. remdesivir/dex. d/c home
Patient was given a higher dose of vaccine than ordered. Pt received 4.5 mcg instead of 3.0 mcq due to not enough diluent being used to mix vaccine. Patient's parent was notified of error and given information regarding signs and symptoms to watch for.
Patient received Pfizer COVID vaccine on 3/30/21 and 4/20/21. On 6/4/22, patient admitted to our inpatient facility (med/surg unit) with acute hypoxic respiratory failure, COVID-19 pneumonia, and acute on chronic COPD exacerbation.  Patient was discharged home earlier today (6/8/22).
Donor immediately had a reaction after the injection of Tdap left deltoid. Donor complained of tingling and itching  in arm and back immediately. EMS called and arrived at center at 9:45am. EMS and Handout given. Donor agreed to be transported By EMS for treatment.